Incidence and predictors of weaning failure from veno-arterial extracorporeal membrane oxygenation therapy in patients with cardiogenic shock, Angela Dettling - Hamburg, 30 August 8:00-8:50
Acute coronary syndromes - get ready for the session, Raphael Twerenbold – Hamburg, 30 August, 8:15-9:15
What’s hot in pulmonary hypertension?, Norbert Frey – Heidelberg, 30 August, 8:15-9:45
Patients with cardiac arrest should be excluded from cardiogenic shock trials: con, Holger Thiele – Leipzig, 30 August, 8:15-9:45
Adjunct pharmacology in PCI: beyond antiplatelet therapy, the next chapter - discussion, Renate B Schnabel – Hamburg, 30 August, 8:15-9:45
Assessing the alignment of obstructive hypertrophic cardiomyopathy pharmacological treatments with ESC guidelines in Germany, Farbod Sedaghat-Hamedani - Heidelberg, 30 August, 13:00-13:50
Neurovascular crosstalk in atherosclerosis, Christian Weber – Munich, 30 August, 13:45-15:00
Artificial intelligence-based management of arrhythmias, Renate B Schnabel – Hamburg, 31 August, 8:15-9:45
Effectiveness of empagliflozin in patients with heart failure and COPD: Results from EMPEROR-Preserved and EMPEROR-Reduced, Stephan von Haehling – Goettingen, 31 August, 9:30-10:30
Genomic and metabolomics in cardiovascular medicine, Tanja Zeller – Hamburg, 31 August, 11:00-12:00
How digital is reshaping cardiac care, Gerhard Hindricks – Berlin, 31 August, 15:30-15:50
The role of mitochondrial dysfunction in atrial fibrillation, Niels Voigt – Goettingen, 31 August, 16:15-17:15
Discussant review – SWEDEGRAFT, Volkmar Falk – Berlin, 31 August, 16:15-17:21
Targeting the right patient for precision therapy, Stefanie Dimmeler – Frankfurt, 31 August, 17:30-18:30
Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: A subanalysis from the DEDICATE-DZHK6 trial, Sabine Bleiziffer - Bad Oeynhausen, 1 September, 8:15-9:45
When to use a pharmaco-invasive approach rather than primary PCI, Adnan Kastrati – Munich, 2 September, 8:15-9:45
Translational proteomics for cardiovascular disease (Prot4CVD Project), Claudia Langenberg – Berlin, 2 September, 11:00-12:00
Sex differences in heart-brain interactions: a neurology perspective, Matthias Endres – Berlin, 2 September, 11:00-12:00
